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Isoenzyme analysis of cultured parasites is the conventional approach for Leishmania species identification.
Molecular approaches have the potential to be more sensitive and rapid. We designed PCR generic primers to
amplify a segment of the rRNA internal transcribed spacer 2 (ITS2) from multiple Leishmania species. To
validate the selected ITS2 fragment, we tested clinical specimens and compared the species results obtained by
the molecular approach (PCR followed by DNA sequencing analysis) with those from the parasitologic
approach (in vitro culture followed by isoenzyme analysis). Among the 159 patients with clinical specimens
positive by both approaches, a total of eight Leishmania species were identified. The species results were
concordant for all but two patients: for one patient, the results were Leishmania (Viannia) guyanensis by the
molecular approach versus L. (V.) braziliensis by the parasitologic approach; for the other patient, the results
were L. (Leishmania) tropica versus L. (L.) major, respectively. ITS2 PCR, followed by sequencing analysis, can
be used to detect and discriminate among Leishmania species. The results confirmed our hypothesis that a
region of the ITS2 gene can complement the characterization of Leishmania parasites at the species level. The
approach we developed can be used as a diagnostic tool in reference laboratories with adequate infrastructure
to perform molecular characterization of pathogens.
Leishmaniasis encompasses multiple clinical syndromes,
most notably, visceral, cutaneous, and mucosal forms (9, 13, 14,
22, 27, 30). Leishmaniasis is endemic in focal areas in the
tropics, subtropics, and southern Europe and is caused by
species in the Leishmania and Viannia subgenera (14). Differ-
ent species can be associated with diverse clinical manifesta-
tions and sequelae. Species identification can facilitate clinical
management, such as decisions regarding whether/which treat-
ment is indicated.
Isoenzyme analysis of cultured parasites is the conventional
diagnostic approach for Leishmania species identification. Mo-
lecular approaches have the potential to be more sensitive and
rapid; e.g., the results can be available within days versus weeks
or months. However, Leishmania PCR-based assays have var-
ied in sensitivity, specificity, and utility for genus- or complex-
level versus species-level characterization (2, 3, 7, 10, 24–26,
28); some approaches have been highly sensitive for genus-
level detection, e.g., PCR methods that target minicircle kin-
etoplast DNA (kDNA), whereas others have been tailored for
particular species/settings.
We sought to develop a comprehensive molecular approach
for characterizing Leishmania species; we focused on the
rRNA internal transcribed spacer (ITS) region, which has been
sequenced by other investigators and proposed as a target for
molecular typing (12, 25). Here we describe our identification
and validation of a diagnostic fragment that was amplified
from the ITS2 with a PCR generic primer pair that we de-
signed. Rather than conduct a formal evaluation of the molec-
ular approach, we focused on demonstrating proof of concept.
By using ITS2 PCR, followed by DNA sequencing analysis of
the amplicons, we were able to discriminate among Leishmania
spp. to complement the diagnosis of leishmaniasis. This
method has been incorporated into the Centers for Disease
Control and Prevention (CDC) algorithm for the laboratory
diagnosis of leishmaniasis, improving the turnaround time for
diagnosis and for decisions regarding treatment of cases of
infection.
MATERIALS AND METHODS
Specimen selection and handling. For the initial evaluations of the Leishmania
ITS2—to identify what we refer to as the diagnostic fragment—we analyzed a
total of 40 cultured isolates previously characterized by isoenzyme analysis and
epidemiologic criteria as Leishmania (Viannia) braziliensis, L. (V.) guyanensis, L.
(V.) panamensis, L. (L.) mexicana, L. (L.) amazonensis, L. (L.) donovani, L. (L.)
infantum, L. (L.) chagasi, L. (L.) aethiopica, L. (L.) major, and L. (L.) tropica
(Table 1).
To validate the diagnostic ITS2 fragment, we analyzed clinical specimens that
were submitted from 2005 to 2009 to our reference laboratory at the CDC for
Leishmania testing. Specimens were used in accordance with a CDC human
subject-approved protocol; no additional specimens were obtained for the mo-
lecular analysis. Per routine, to the extent possible, the specimens were shipped
by overnight mail; almost all of the specimens were from skin biopsies, and
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specimens typically were shipped in a sterile tube containing RPMI medium that
CDC provided in advance. Upon arrival at the CDC, specimens were divided
into portions for the parasitologic and molecular analyses described below.
When possible, stained slides (e.g., histopathology slides provided by the prac-
titioner or impression smears/wet mounts made by the CDC) were examined by
light microscopy for amastigotes; the slides were not necessarily from the same
specimens that were tested by culture and PCR.
Culture and isoenzyme analysis. The culture tubes contained Novy-MacNeal-
Nicolle agar with 10% defibrinated rabbit blood and an overlay of RPMI medium
with 15% fetal bovine serum. The tubes were incubated at 25°C; aliquots were
examined by light microscopy two to three times a week until promastigotes were
noted or 4 weeks had elapsed. Positive cultures were transferred from tubes to
large flasks containing 20 ml of fresh RPMI medium to facilitate obtaining
large numbers of parasites for isoenzyme analysis. In brief, after the parasites
again reached log phase, the liquid culture medium that was harvested from the
flasks was centrifuged at 850  g for 15 min (in phosphate-buffered saline [PBS],
pH 7.2), the pellet was frozen, and fresh RPMI medium was added to the flasks,
which were placed back into the incubator. This process was repeated several
times, using the same tube to harvest the pellet. After the final harvest, the
composite pellet was treated with 50 to 100 l of lysis buffer (0.1 M Tris, 0.1 M
malic acid, 0.1 M EDTA, and 0.1 M MgCl2); the mixture was subjected to several
freeze-thaw cycles at 70°C, and the lysate was stored in liquid nitrogen pending
isoenzyme analysis. Cellulose acetate electrophoresis was performed, based on
protocols developed by Kreutzer et al. (15–17), targeting isoenzymes 6-phospho-
D-gluconate dehydrogenase (6PGDH) and glucose phosphate isomerase (GPI).
Identification of the diagnostic ITS2 fragment. DNA was extracted from the
40 banked, frozen cultured isolates—also referred to as the reference iso-
lates—by using a QIAamp DNA Micro Kit (Qiagen), following the manufactur-
er’s instructions. To amplify the ITS region, we used a previously described
strategy (12) and cloned the fragments as described below. To identify/select the
diagnostic ITS2 fragment, we conducted multiple alignments of the full-length
ITS sequence (data not shown); the sequence of the ITS2 region of each Leish-
mania species was identified by searching the GenBank database using the
BLAST algorithm. On the basis of this analysis, we found a variable region within
nucleotide positions 392 and 809 [using L. (L.) donovani GenBank entry
FJ753386 as a reference], designed the generic primers LGITSF2 (GCATGCC
ATATTCTCAGTGTC) and LGITSR2 (GGCCAACGCGAAGTTGAATTC)
for this region, and used this primer pair to reamplify the DNA previously
extracted from the 40 reference isolates.
For PCR, the total volume per reaction mixture was 50 l, which included 1 l
of DNA, 0.2 M each primer, 0.2 mM each deoxynucleoside triphosphate
(dNTP), 1.5 mM MgCl2, and 2.5 U of AmpliTaq Gold PCR polymerase (Applied
Biosystems). PCR was performed in a GeneAmp PCR System 9700 thermocycler
(Applied Biosytems), using the following cycle structure: 95°C for 5 min, fol-
lowed by 40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min, with a final
extension of 72°C for 7 min. The amplicons were purified with a StrataPrep PCR
Purification Kit (Stratagene) and cloned with a pCR2.1-TOPO vector TOP10 Kit
(Invitrogen). The clones were purified by using a QIAprep Spin Miniprep Kit
(Qiagen) and sequenced by using BigDye, version 3.1, chemistry (Applied Bio-
systems). The sequencing reaction mixtures were purified by using Multi-
Screen-HV plates (Millipore) and were analyzed on an ABI Prism 3100 se-
quencer, with data collection software, version 2.0, and DNA Sequencing
Analysis Software, version 5.1 (Applied Biosystems). The sequences were assem-
bled, edited, and aligned by using the DNA STAR SeqMan (DNASTAR Inc.)
and the GeneStudio suite (GeneStudio Inc.) programs.
We also designed an alternative reverse generic primer named LGITS2R1
(GAATTCTCGTTTTGGTTTTTTG), at positions 773 to 794 of the L. (L.)
donovani reference (GenBank entry FJ753386), to compensate for the CG de-
letion and the G/T transversion in the LGITS2R2 primer binding region of L.
(L.) amazonensis and L. (L.) aethiopica, respectively. We compared the PCR
results obtained with three primer combinations—LGITSF2/LGITSR2,
LGITSF2/LGITSR1, and LGITSF2/LGITSR1/LGITSR2—on seven cultured
isolates of L. (L.) amazonensis and three of L. (L.) aethiopica, besides at least five
isolates of each of the other pertinent species (Table 1). The amplicons were
resolved with 1.5% agarose gels and visualized by staining with ethidium bro-
mide.
Validation of the diagnostic ITS2 fragment. DNA was extracted directly from
the clinical specimens (i.e., from 5 to 10 mg of tissue and 100 to 200 l of
blood or bone marrow) by using the method described above. PCR amplifica-
tions using generic primers LGITSF2/LGITSR2 were performed in a final reac-
tion volume of 50 l as described above, except that the aliquot of specimen
DNA was 5 (versus 1) l, diluted at 1:1 and 1:5. Sequencing reactions were
performed directly from the amplicons by using the parameters described above.
The initial molecular testing of the clinical specimens was blinded such that
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L. (V.) braziliensis 4 (1; 3) MHOM/BR/75/M2903 383–394 8 AT (69, 118); TC
(266)
L. (V.) guyanensis 4 (1; 3) MHOM/BR/75/M4147* 386–389 4 AT (137)
L. (V.) panamensis 4 (1; 3) MHOM/PA/71/LS94* 372–389 5 TA (68); AT (117);
TC (266)
L. (L.) mexicana 4 (2; 2) MNYC/BZ/62/M379*; MHOM/BZ/82/BEL21 436–438 5 TA (61); AT (141)
L. (L.) amazonensis 4 (2; 2) IFLA/BR/67/PH8*; MHOM/BR/73/M2269 446–450 2 TA (63); GA (362)
L. (L.) donovani 4 (2; 2) MHOM/IN/80/DD8*; MHOM/ET/67/HU3 416–420 4 TA (60)
L. (L.) infantum 2 (1; 1) MHOM/TN/80/LEM235* 418–420 2 TA (60)
L. (L.) chagasi 3 (1; 2) MHOM/BR/74/M2682* 418–420 2 TA (60)
L. (L.) aethiopica 3 (1; 2) MHOM/ET/72/L100 424–428 4 AT (58); TC (264)
L. (L.) major 4 (3; 1) MHOM/IL/67/JERICHO II*; MHOM/SU/73/5-ASKH;
MRHO/SU/59/P-strain
430–438 3 AT (129); TG (146)
L. (L.) tropica 4 (2; 2) MHOM/SU/74/K27*; MHOM/SU/58/L39 406–415 9 AT (69, 129); TG
(147); TC (269);
GA (352)
a The 40 cultured isolates include 17 from the WHO and 23 from the CDC. The international codes for the WHO strains are provided. For the purposes of these
analyses, CDC’s L. (L.) infantum (Old World isolate), L. (L.) chagasi (New World isolates), and L. (L.) donovani strains were defined on the basis of epidemiologic/
geographic criteria.
b Nine WHO isolates () were used to amplify the full-length ITS sequence, as were isolates from the CDC. Overall, we deposited in GenBank the complete ITS
sequences for L. (V.) braziliensis (accession numbers FJ753374 to FJ753385), L. (V.) guyanensis (FJ753387 to FJ753390), L. (V.) panamensis (FJ948438 to FJ948446),
L. (L.) mexicana (FJ948432 to FJ948437), L. (L.) amazonensis (FJ753371 to FJ753373), L. (L.) donovani (FJ753386, GU045589, and GU045590), L. (L.) chagasi
(GU045591), L. (L.) infantum (GU045592), L. (L.) aethiopica (GQ920673 to GQ920677), L. (L.) major (FJ753391 to FJ753395), and L. (L.) tropica (FJ948447 to
FJ948465).
c Ten clones per amplicon were analyzed.
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isoenzyme results were not known. However, for some specimens, if the species
results differed from those obtained by the parasitologic approach (e.g., negative
versus positive), the molecular testing was repeated. If residual specimen was
available, DNA was reextracted; otherwise, DNA from the original extraction
was reamplified. The species results obtained by isoenzyme analysis were con-
sidered the gold standard.
Quality assurance. Each DNA extraction batch included a negative control,
i.e., DNA extracted from Leishmania-free eukaryotic cell cultures (E-6 cells in
RPMI medium). For each PCR run, a tube containing water and PCR mix was
used as a negative control (blank), and approximately 1 pg of the cloned full-
length ITS region was used as a positive control. Separate rooms were used for
DNA extraction, PCR Master Mix preparation, DNA loading onto the Master
Mix, loading of the positive control, and electrophoretic analysis of amplicons.
RESULTS
Sequence divergence in the ITS2 among reference isolates.
Use of the ITS2 generic primer pair LGITSF2/LGITSR2 to
amplify DNA from the 40 cultured isolates produced am-
plicons that ranged from 372 to 450 bp in length (Table 1).
The PCR results obtained by using different primer
combinations—LGITSF2/LGITSR1, LGITSF2/LGITSR1/
LGITSR2, or LGITSF2/LGITSR2—were comparable (Fig.
1A, B, and C), which suggests that either or both reverse
primers (LGITSR1 and LGITSR2) can be used with the
forward primer LGITSF2. We used LGITSF2/LGITSR2 to
accomplish the validation described below.
Alignment of the ITS2 sequences showed that amplicons
from the same species or even the same specimen varied in
length, mainly because of AT, TC, TG, or GA microsatellite
repeats (Table 1). To simplify the analysis, these discrepant
repeat regions were removed, which yielded intraspecies se-
quences of comparable lengths. However, because of a few
transitions and transversions, more than one sequence per
species or isolate was found. Therefore, the few variant se-
quences were removed, and the resulting identical sequences
were considered the consensus sequences.
In some instances, direct sequencing analysis of LGITSF2/
LGITSR2 amplicons showed degraded regions, with multiple
overlapping peaks after well-resolved regions, because of the
regions with variant repeats. One example is the AT microsat-
ellite starting at nucleotide positions 118 and 129 observed in
the amplicons obtained from L. (V.) braziliensis (MHOM/BR/
75/M2903) and L. (L.) tropica (MHOM/SU/74/K27) WHO ref-
erence strains. Although the partial sequences sufficed for cor-
rect species identification by BLAST search, we cloned the
reference strain amplicons to obtain the complete sequence of
the fragment. Alignment of sequences obtained by randomly
selecting one clone per species (from the identical group of
sequences) showed sufficient divergence for discrimination
both between and among species complexes/subgenera.
FIG. 1. (A) Agarose gel electrophoresis showing amplicons produced with generic primers LGITSF2/LGITSR1. (B). Agarose gel electropho-
resis showing amplicons produced with generic primers LGITSF2/LGITSR1/LGITSR2. (C) Agarose gel electrophoresis showing amplicons
produced with generic primers LGITSF2/LGITSR2. For all panels, DNA was extracted from the following cultures: lanes 1, L. (V.) braziliensis;
lanes 2, L. (L.) mexicana; lanes 3, L. (L.) amazonensis; lanes 4, L. (L.) donovani; lanes 5, L. (L.) major; lanes 6, L. (L.) tropica; and lanes 7, L. (L.)
aethiopica. Lanes L, 100-bp ladder size standards. Numbers to the left indicate the DNA fragment size in bp.
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The L. (L.) donovani species complex had a stretch of Gs (a
G stretch) that started at nucleotide position 343 [using L. (L.)
donovani FJ753386 as a reference]. The reference strains of L.
(L.) infantum and L. (L.) chagasi were indistinguishable; there-
fore, we have used the nomenclature “L. (L.) infantum/cha-
gasi.” However, the G stretch typically was longer for L. (L.)
infantum/chagasi (7 or 9 Gs) than for L. (L.) donovani (5 Gs).
Two of the four L. (L.) donovani strains, including the WHO
strain from Asia, had a G/T transversion at position 345, re-
ferred to as G345T (Fig. 2).
Among the sequences for the three Viannia spp. in the
analyses (Table 1), we consistently found sites for species-level
identification in the clones that we sequenced from each iso-
late; the species were differentiated on the basis of four single
nucleotide polymorphisms (SNPs), i.e., an A/C transversion at
nucleotide position 59 (referred to as A59C transversion), a
G220A transition, a G297A transition, and a G317A transition
[positions are based on the sequences of L. (V.) braziliensis
FJ753376, L. (V.) guyanensis FJ753387, and L. (V.) panamensis
FJ948438]. Leishmania (V.) braziliensis was distinguished from
the other Viannia spp. by the presence of nucleotides A, G, G,
and G at positions 59, 220, 297, and 317, respectively; L. (V.)
guyanensis and L. (V.) panamensis were distinguished from
each other on the basis of the transition G220A. Figure 2
shows the differences that allowed species identification.
Validation of ITS2 PCR as a diagnostic tool. The ITS2
fragment was amplified directly from clinical specimens (versus
cultures), the amplicons were sequenced, and the species was
identified on the basis of criteria described for the reference
isolates, including the SNPs and G stretch (Fig. 2). If direct
sequencing analysis showed overlapping peaks because of vari-
ant microsatellites, partial sequences were used to identify the
species; no cloning was done.
Species-level characterization was accomplished by this mo-
lecular approach (PCR followed by DNA sequencing analysis)
for specimens from 202 patients, including 13 (6%) for whom
the positive results were obtained on repeat testing (Table 2).
We compared the species data with data from the parasitologic
approach (in vitro culture followed by isoenzyme analysis). Of
necessity, the comparison was limited to the 159 patients for
whom species results were obtained by both approaches. For
all but 2 of these 159 patients, the results were concordant.
One of the two exceptions was in the Viannia subgenus: L. (V.)
guyanensis was identified by the molecular approach, whereas
L. (V.) braziliensis was identified by the parasitologic approach.
DNA from this specimen was reamplified and resequenced
thrice, and the same result was obtained each time. The other
exception was a discordance between L. (L.) tropica (by PCR
and sequence analysis) and L. (L.) major (by culture and isoen-
zyme analysis). DNA from these specimens was reamplified
and resequenced twice, and the same results were obtained
each time.
The comparative data were limited to the L. (L.) donovani
species complex as a whole because isoenzyme analysis using
6PGDH and GPI does not distinguish L. (L.) donovani from L.
(L.) infantum/chagasi. In general, the molecular approach ap-
FIG. 2. Alignment of the variant regions of the ITS2 Leishmania sequences generated by PCR using generic primers LGITSF2/LGITSR2. The
highlighted positions indicate the SNPs that differentiate L. (V.) braziliensis, L. (V.) guyanensis, and L. (V.) panamensis from each other, and the
G stretch and SNP that differentiate between L. (L.) donovani and L. (L.) infantum/chagasi. The L. (L.) donovani sequence in the figure has a G/T
transversion at nucleotide position 345 (referred to as G345T); i.e., the sequence for positions 343 to 347 is GGTGG rather than GGGGG. The
variations in the LGITS2R2 primer binding regions of L. (L.) amazonensis and L. (L.) aethiopica are shown at nucleotide block 461. The original
length of each sequence in the base pairs (bp) is indicated at the 3 end of the sequence.
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peared to be more sensitive than the parasitologic approach
for detecting parasites in this species complex; i.e., specimens
were positive for 29 versus 14 patients, respectively. By using
molecular criteria described for the reference isolates (Fig. 2),
L. (L.) infantum/chagasi was the etiologic agent for all but 6 of
these 29 patients, including 14 of the 15 with negative cultures.
For the other six patients, the species was identified by the
molecular approach as L. (L.) donovani; four of these six
patients became infected in Central and South America, where
L. (L.) infantum/chagasi would be the expected species (Ta-
ble 2).
DISCUSSION
Various molecular approaches for diagnosing Leishmania
infection have been described. For example, PCR methods
that target minicircle kDNA can be highly sensitive for detect-
ing Leishmania parasites because of the abundance of
minicircles in each kinetoplast (2, 7, 10). However, high-level
sequence polymorphism among minicircles is an impediment
for species identification with protocols based solely on kDNA
PCR. Targeting the rRNA-coding cluster poses other issues (7,
32). Highly sensitive approaches for identifying particular
Leishmania species (or a species complex/subgenus) have been
described (8, 25). However, if multiple Leishmania spp. need
to be differentiated in a diagnostic laboratory, molecular ap-
proaches that require different PCR primers for each species
have the potential for carryover contamination. Although
strategies to minimize this potential have been developed (5),
contamination has been observed even when strict protocols
were followed (20, 23).
Our goal was to develop a molecular approach for species-
level discrimination that requires only one pair of PCR prim-
ers. We focused on the ITS region: the rRNA internal spacers
are subject to less evolutionary pressure and show more se-
quence divergence than the coding regions and have been
proposed as targets for molecular typing (1, 6, 19). We iden-
tified a region of the ITS2 adequate for our diagnostic goal and
designed generic PCR primers (LGITSF2/LGITSR2) to am-
plify this fragment from Leishmania spp. associated with hu-
man infection. We found substantial differences in the ITS2
region spanned by these primers that generally allowed species
identification.
During our analysis of the reference strains, we noted in-
traspecies variability in the AT, TC, TG, or GA microsatellite
repeats, as have other investigators (12, 18, 25, 31), which
initially hindered use of the ITS2 fragment for species identi-
fication. We also noted some distinct sequences because of a
few transitions and transversions. In most instances, distinct
sequences were found in clones obtained from the same iso-
late, which likely indicated the presence of multiple different
ITS copies in the same genome. To exclude the possibility of
erroneous incorporation of nucleotides (11, 29), we reampli-
fied the DNA from some specimens by using Pfu High-Fidelity
DNA polymerase (Stratagene); the results were the same as
those with the routinely used Taq DNA polymerase (data not
shown). During the development phase of the assay, we cloned
reference strain amplicons to obtain the sequence of the entire
TABLE 2. Number of patients with Leishmania spp. identified by ITS2 PCR followed by DNA sequencing, compared with culture followed
by isoenzyme analyzesa
Species identified














L. (V.) braziliensis 30 (5) 6 28 3 25 24 (vs 25) identified by molecular
approach as L. (V.) braziliensis
L. (V.) guyanensis 9 (0) 4 5 1 4 5 (vs 4) identified by molecular
approach as L. (V.) guyanensis
L. (V.) panamensis 67 (2) 10 64 7 57
L. (L.) mexicana 33 (1) 2 34 3 31
L. (L.) donovani complexc 29 (2) 15 14 0 14
L. (L.) aethiopica 2 (1) 0 2 0 2
L. (L.) major 23 (2) 5 22 3 19 18 (vs 19) identified by molecular
approach as L. (L.) major
L. (L.) tropica 9 (0) 1 8 1 7 8 (vs 7) identified by molecular
approach as L. (L.) tropica
Total no. of patients 202 (13)d 43e 177 18 159 Overall, the species results were
discordant for 2 patients
a The generic primer pair used for ITS2 PCR was LGITSF2/LGITSR2. Overall, specimens from 220 patients were positive by one or both approaches, i.e., 202 plus
18. Among the 159 patients with specimens positive by both approaches, the results were discordant for two patients: for a patient exposed in Ecuador, the results were
L. (V.) guyanensis by the molecular approach versus L. (V.) braziliensis by culture/isoenzyme analysis; for the other patient, who had traveled to Morocco, Kenya, and
Spain, the discordance was between L. (L.) tropica and L. (L.) major. Leishmania (L.) amazonensis is not included in the Table because none of the clinical specimens
were positive for this species.
b Positive result, species was identified. IE, isoenzyme.
c The sequences of the ITS2 diagnostic fragment for specimens from three patients exposed in Central America (two patients) or South America (one patient) had
the GGGGG stretch; specimens from three other patients exposed in Asia, East Africa, or Central America (one each) had the G stretch with the transversion G435T
(Fig. 2).
d The 13 patients with positive results on repeat testing are included in the total number of patients positive by PCR and not in the number of positive by IE only.
e Amastigotes were detected by light microscopic examination of slides for 22 of these 43 patients (for 22 of 37 patients with available slides) (see Materials and
Methods).
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diagnostic fragment for each species, and we demonstrated
that partial sequences sufficed for species identification. There-
fore, in the validation phase, when we tested clinical speci-
mens, we used direct sequencing analysis, without cloning, and
in some instances relied on partial sequence data.
The distribution of species among the clinical specimens
[e.g., the disproportionate number of patients infected with L.
(V.) panamensis] reflects travel and immigration patterns
among U.S. civilians evaluated for leishmaniasis; almost all of
the clinical specimens we analyzed were from skin lesions.
Although the PCR results obtained with different combina-
tions of the reverse primers LGITSR1 and LGITSR2 were
comparable for the isolates tested (Fig. 1A, B, and C), we had
insufficient numbers of specimens positive for L. (L.) ama-
zonensis and L. (L.) aethiopica—the species that prompted us
to design the alternative reverse primer (LGITS2R1)—to com-
pare the sensitivities of the primer pairs. We correctly identi-
fied the species as L. (L.) amazonensis for seven cultured
isolates (including two WHO reference strains). However, this
species was not identified by the parasitologic or molecular
approach for any clinical specimens (Table 2). For L. (L.)
aethiopica, the analyses included three cultured isolates (in-
cluding one from WHO) and two clinical specimens (Tables 1
and 2).
The overall agreement between the molecular and parasito-
logic approaches was 98% when the comparison, of neces-
sity, was limited to specimens for which a species determina-
tion was accomplished by both approaches. The two discordant
results (among 159 patients) remained unresolved: for one
patient, L. (V.) guyanensis was identified by the molecular
approach versus L. (V.) braziliensis by the parasitologic ap-
proach (culture followed by isoenzyme analysis), and for the
other patient, L. (L.) tropica was identified versus L. (L.) ma-
jor, respectively. No other methods were used to evaluate the
specimens; both results were epidemiologically plausible (Ta-
ble 2), and the possibility of coinfection or of variant strains
could not be excluded.
In general, our molecular approach differentiated among
Viannia spp., namely, L. (V.) braziliensis, L. (V.) guyanensis,
and L. (V.) panamensis, on the basis of four SNPs that appear
to be in linkage disequilibrium with the genes that code for the
isoenzymes we used to differentiate them (i.e., 6PGDH and
GPI). These species, each of which likely is heterogeneous,
have been associated with phenotypic (clinical) differences,
which underscores the importance of species-level diagnostic
techniques (4, 14, 22).
Our molecular approach did not differentiate L. (L.) infan-
tum from L. (L.) chagasi, which many experts consider synon-
ymous (18, 21). However, some distinguishing features in the
ITS2 fragment were noted between the reference isolates of L.
(L.) donovani versus L. (L.) infantum/chagasi, i.e., the length of
a G stretch and, for the WHO L. (L.) donovani strain from
Asia, a G435T transversion. Similar variation has been re-
ported previously for some L. (L.) donovani strains (18). How-
ever, for several clinical specimens [four of the six classified as
L. (L.) donovani], the approach we used appears to have re-
sulted in misclassification of L. (L.) infantum/chagasi as L. (L.)
donovani. Additional experience with more specimens from
more areas of endemicity is needed to ascertain the ability of
this ITS2 molecular target to reliably distinguish L. (L.) don-
ovani from L. (L.) infantum/chagasi.
Approximately half of the patients with negative cultures but
positive PCR results had slides available that were positive by
light microscopic examination (Table 2), thereby confirming
the diagnosis of leishmaniasis and underscoring the plausibility
of PCR positivity. In some instances, negative culture (versus
molecular) results might have been attributable to fastidious or
nonviable parasites in the specimens we received or to con-
tamination of the cultures, e.g., because of suboptimal han-
dling or delayed shipment to the CDC. Lack of PCR positivity
for some of the culture-positive specimens might have been
attributable to heterogeneous distributions of parasites in
specimens, such that the parasite/DNA concentration in the
portion analyzed by PCR was below the detection limit of the
assay. Preliminary data from a 40-cycle SYBR green-based
real-time PCR assay under development in our laboratory sug-
gest that positive specimens with threshold cycle (CT) values
around 35 could be negative by ITS2 PCR and/or culture
(M. E. de Almeida, unpublished data).
A drawback of our approach is the need for DNA sequenc-
ing analysis, which is not yet available in most laboratories in
areas of endemicity. However, the ITS2 fragment has cleavage
sites for HinP1I or HhaI enzymes (GCGC) and MnlI enzyme
(GAGG) that may have utility for identifying the species we
evaluated except for those in the Viannia subgenus. A cleavage
site for HphI (GGTGAN7) could be used to identify L. (V.)
guyanensis but not L. (V.) braziliensis or L. (V.) panamensis.
These cleavage sites could be explored as targets for restriction
fragment length polymorphism analysis to distinguish among a
few species by laboratories in which DNA sequencing analysis
is not yet available.
In summary, our findings confirm our hypothesis that a re-
gion of the ITS2 gene can complement the characterization of
Leishmania parasites at the species level. The approach we
developed can be used as a diagnostic tool in reference labo-
ratories that have adequate infrastructure to perform molecu-
lar characterization of pathogens.
ACKNOWLEDGMENT
We are indebted to Patricia Wilkins from the Centers for Disease
Control and Prevention for invaluable assistance in reviewing the man-
uscript.
The findings and conclusions in this report are those of the authors
and do not necessarily represent the official position of CDC.
REFERENCES
1. Adam, R. D., Y. R. Ortega, R. H. Gilman, and C. R. Sterling. 2000. Inter-
vening transcribed spacer region 1 variability in Cyclospora cayetanensis.
J. Clin. Microbiol. 38:2339–2343.
2. Anders, G., C. L. Eisenberger, F. Jonas, and C. L. Greenblatt. 2002. Distin-
guishing Leishmania tropica and Leishmania major in the Middle East using
the polymerase chain reaction with kinetoplast DNA-specific primers. Trans.
R. Soc. Trop. Med. Hyg. 96(Suppl. 1):S87–S92.
3. Antinori, S., et al. 2007. Clinical use of polymerase chain reaction performed
on peripheral blood and bone marrow samples for the diagnosis and mon-
itoring of visceral leishmaniasis in HIV-infected and HIV-uninfected pa-
tients: a single-center, 8-year experience in Italy and review of the literature.
Clin. Infect. Dis. 44:1602–1610.
4. Arevalo, J., et al. 2007. Influence of Leishmania (Viannia) species on the
response to antimonial treatment in patients with American tegumentary
leishmaniasis. J. Infect. Dis. 195:1846–1851.
5. Aslanzadeh, J. 2004. Preventing PCR amplification carryover contamination
in a clinical laboratory. Ann. Clin. Lab Sci. 34:389–396.
6. Barta, J. R., et al. 1998. Analysis of infraspecific variation among five strains
of Eimeria maxima from North America. Int. J. Parasitol. 28:485–492.
3148 DE ALMEIDA ET AL. J. CLIN. MICROBIOL.
7. Bensoussan, E., A. Nasereddin, F. Jonas, L. F. Schnur, and C. L. Jaffe. 2006.
Comparison of PCR assays for diagnosis of cutaneous leishmaniasis. J. Clin.
Microbiol. 44:1435–1439.
8. Cruz, I., et al. 2002. A nested polymerase chain reaction (Ln-PCR) for
diagnosing and monitoring Leishmania infantum infection in patients co-
infected with human immunodeficiency virus. Trans. R. Soc. Trop. Med.
Hyg. 96(Suppl. 1):S185–S189.
9. Desjeux, P. 2004. Leishmaniasis: current situation and new perspectives.
Comp. Immunol. Microbiol. Infect. Dis. 27:305–318.
10. Disch, J., et al. 2005. Leishmania (Viannia) subgenus kDNA amplification
for the diagnosis of mucosal leishmaniasis. Diagn. Microbiol. Infect. Dis.
51:185–190.
11. Eckert, K. A., and T. A. Kunkel. 1991. DNA polymerase fidelity and the
polymerase chain reaction PCR Methods Appl. 1:17–24.
12. el Tai, N. O., O. F. Osman, M. el Fari, W. Presber, and G. Schonian. 2000.
Genetic heterogeneity of ribosomal internal transcribed spacer in clinical
samples of Leishmania donovani spotted on filter paper as revealed by
single-strand conformation polymorphisms and sequencing. Trans. R. Soc.
Trop. Med. Hyg. 94:575–579.
13. Guerin, P. J., et al. 2002. Visceral leishmaniasis: current status of control,
diagnosis, and treatment, and a proposed research and development agenda.
Lancet Infect. Dis. 2:494–501.
14. Herwaldt, B. L. 1999. Leishmaniasis. Lancet 354:1191–1199.
15. Kreutzer, R. D. 1996. Genetic similarity among Central and South American
populations of Leishmania (Viannia) braziliensis. Am. J. Trop. Med. Hyg.
55:106–110.
16. Kreutzer, R. D., and H. A. Christensen. 1980. Characterization of Leish-
mania spp. by isozyme electrophoresis. Am. J. Trop. Med. Hyg. 29:199–208.
17. Kreutzer, R. D., M. E. Semko, L. D. Hendricks, and N. Wright. 1983.
Identification of Leishmania spp. by multiple isozyme analysis. Am. J. Trop.
Med. Hyg. 32:703–715.
18. Kuhls, K., I. L. Mauricio, F. Pratlong, W. Presber, and G. Schonian. 2005.
Analysis of ribosomal DNA internal transcribed spacer sequences of the
Leishmania donovani complex. Microbes Infect. 7:1224–1234.
19. Kuwahara, K., et al. 2009. Genetic diversity of ribosomal RNA internal
transcribed spacer sequences in Lutzomyia species from areas endemic for
New World cutaneous leishmaniasis. Acta Trop. 112:131–136.
20. Laurent, T., et al. 2009. Identification of Old World Leishmania spp. by
specific polymerase chain reaction amplification of cysteine proteinase B
genes and rapid dipstick detection. Diagn. Microbiol. Infect. Dis. 63:173–
181.
21. Mauricio, I. L., J. R. Stothard, and M. A. Miles. 2000. The strange case of
Leishmania chagasi. Parasitol. Today 16:188–189.
22. Murray, H. W., J. D. Berman, C. R. Davies, and N. G. Saravia. 2005.
Advances in leishmaniasis. Lancet 366:1561–1577.
23. Odiwuor, S. O. C., et al. 2011. Universal PCR assays for the differential
detection of all Old World Leishmania species. Eur. J. Clin. Microbiol.
Infect. Dis. 30:209–218.
24. Parvizi, P., I. Mauricio, A. M. Aransay, M. A. Miles, and P. D. Ready. 2005.
First detection of Leishmania major in peridomestic Phlebotomus papatasi
from Isfahan province, Iran: comparison of nested PCR of nuclear ITS
ribosomal DNA and semi-nested PCR of minicircle kinetoplast DNA. Acta
Trop. 93:75–83.
25. Parvizi, P., and P. D. Ready. 2008. Nested PCRs and sequencing of nuclear
ITS-rDNA fragments detect three Leishmania species of gerbils in sandflies
from Iranian foci of zoonotic cutaneous leishmaniasis. Trop. Med. Int.
Health 13:1159–1171.
26. Reithinger, R., and J. C. Dujardin. 2007. Molecular diagnosis of leishman-
iasis: current status and future applications. J. Clin. Microbiol. 45:21–25.
27. Reithinger, R., et al. 2007. Cutaneous leishmaniasis. Lancet Infect. Dis.
7:581–596.
28. Rotureau, B., et al. 2006. Molecular epidemiology of Leishmania (Viannia)
guyanensis in French Guiana. J. Clin. Microbiol. 44:468–473.
29. Sala, M., V. Pezo, S. Pochet, and S. Wain-Hobson. 1996. Ambiguous base
pairing of the purine analogue 1-(2-deoxy-beta-D-ribofuranosyl)-imidazole-
4-carboxamide during PCR. Nucleic Acids Res. 24:3302–3306.
30. Schwartz, E., C. Hatz, and J. Blum. 2006. New world cutaneous leishman-
iasis in travellers. Lancet Infect. Dis. 6:342–349.
31. Tashakori, M., et al. 2006. Leishmania major: genetic heterogeneity of Ira-
nian isolates by single-strand conformation polymorphism and sequence
analysis of ribosomal DNA internal transcribed spacer. Acta Trop. 98:52–58.
32. van Eys, G. J., G. J. Schoone, N. C. Kroon, and S. B. Ebeling. 1992. Sequence
analysis of small subunit rRNA genes and its use for detection and identi-
fication of Leishmania parasites. Mol. Biochem. Parasitol. 51:133–142.
VOL. 49, 2011 IDENTIFICATION OF LEISHMANIA SPP. BY ITS2 SEQUENCING 3149
